[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE220543T1 - Rasch-freisetzende ph-unabhängige feste dosisformen enthaltend cisaprid - Google Patents

Rasch-freisetzende ph-unabhängige feste dosisformen enthaltend cisaprid

Info

Publication number
ATE220543T1
ATE220543T1 AT97200715T AT97200715T ATE220543T1 AT E220543 T1 ATE220543 T1 AT E220543T1 AT 97200715 T AT97200715 T AT 97200715T AT 97200715 T AT97200715 T AT 97200715T AT E220543 T1 ATE220543 T1 AT E220543T1
Authority
AT
Austria
Prior art keywords
rapid
release
forms containing
dose forms
solid dose
Prior art date
Application number
AT97200715T
Other languages
English (en)
Inventor
Paul Marie Victor Gilis
Guido Franciscus Smans
Guido Jozef Maria Gijs
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE220543T1 publication Critical patent/ATE220543T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97200715T 1996-04-23 1997-03-11 Rasch-freisetzende ph-unabhängige feste dosisformen enthaltend cisaprid ATE220543T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96201078 1996-04-23

Publications (1)

Publication Number Publication Date
ATE220543T1 true ATE220543T1 (de) 2002-08-15

Family

ID=8223900

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97200715T ATE220543T1 (de) 1996-04-23 1997-03-11 Rasch-freisetzende ph-unabhängige feste dosisformen enthaltend cisaprid

Country Status (23)

Country Link
US (1) US6030988A (de)
JP (1) JPH10510559A (de)
KR (1) KR100204115B1 (de)
CN (1) CN1216467A (de)
AR (1) AR006790A1 (de)
AT (1) ATE220543T1 (de)
AU (1) AU720582B2 (de)
BG (1) BG102812A (de)
BR (1) BR9708585A (de)
CA (1) CA2201264C (de)
CZ (1) CZ332598A3 (de)
DE (1) DE69713948D1 (de)
EA (1) EA000804B1 (de)
EE (1) EE03552B1 (de)
ID (1) ID16666A (de)
IL (1) IL125979A0 (de)
NO (1) NO984016L (de)
NZ (1) NZ331705A (de)
PL (1) PL328917A1 (de)
SK (1) SK144698A3 (de)
TR (1) TR199802139T2 (de)
WO (1) WO1997039744A1 (de)
ZA (1) ZA973449B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US20030138485A1 (en) * 1998-01-14 2003-07-24 Daiichi Pharmaceutical Co., Ltd. Disintegrant
WO1999053918A1 (fr) * 1998-04-20 1999-10-28 Eisai Co., Ltd. Compositions stabilisees contenant des composes du type benzimidazole
TW407058B (en) * 1998-07-17 2000-10-01 Dev Center Biotechnology Oral cisapride dosage forms with an extended duration
US6353005B1 (en) * 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
EP1222922B1 (de) 1999-10-20 2007-08-15 Eisai R&D Management Co., Ltd. Methode zur stabilisierung von benzimidazol-verbindungen
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
SE0100200D0 (sv) * 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
US6407128B1 (en) 2001-12-03 2002-06-18 Elan Pharmaceuticals, Inc. Method for increasing the bioavailability of metaxalone
US7714006B1 (en) 2001-12-03 2010-05-11 King Pharmaceuticals Research & Development, Inc. Methods of modifying the bioavailability of metaxalone
DE10164510A1 (de) * 2001-12-20 2003-07-10 Schering Ag Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes
EP1321142A1 (de) * 2001-12-21 2003-06-25 Novartis AG Feste orale Zubereitung mit Tegaserod
HRP20020124A2 (en) * 2002-02-11 2003-10-31 Pliva D D Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
GB2390541A (en) * 2002-07-12 2004-01-14 Reckitt Benckiser Healthcare Medicinal composition comprising fibre or saccharide bulking agents
AU2003276688A1 (en) * 2002-09-02 2004-03-19 Sun Pharmaceutical Industries Limited Pharmaceutical composition of metaxalone with enhanced oral bioavailability
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
TWI398273B (zh) * 2003-07-18 2013-06-11 Santarus Inc 用於抑制酸分泌之醫藥調配物及其製備及使用之方法
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2531566C (en) * 2003-07-18 2013-05-07 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8524736B2 (en) 2004-01-07 2013-09-03 Armetheon, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US8138204B2 (en) * 2004-01-07 2012-03-20 Aryx Therapeutics, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
WO2005076987A2 (en) * 2004-02-10 2005-08-25 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
EP1742630A4 (de) * 2004-04-16 2010-01-20 Santarus Inc Kombination aus protonenpumpenhemmer, puffermittel und prokinetischem wirkstoff
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8022053B2 (en) * 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
EA015155B1 (ru) 2005-05-26 2011-06-30 Тева Вуменс Хелс, Инк. Дозированные формы для перорального применения, содержащие прогестерон, и способы их изготовления и использования
CN1935264B (zh) * 2005-09-23 2010-05-05 北京德众万全医药科技有限公司 一种用于缓控释片的含有hpmc的新型复合辅料
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
TW200843802A (en) * 2007-02-09 2008-11-16 Drugtech Corp Compositions for improving gastrointestinal nutrient and drug absorption
CN104352465B (zh) * 2014-11-17 2017-04-12 成都新恒创药业有限公司 一种不含二氧化硅的琥珀酸普芦卡必利药物组合物及其制备方法
CN109394711A (zh) * 2018-11-06 2019-03-01 威海贯标信息科技有限公司 一种酒石酸西尼必利片组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962115A (en) * 1981-10-01 1990-10-09 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives
WO1994001112A1 (en) * 1992-07-07 1994-01-20 Sepracor Inc. Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
CA2139636A1 (en) * 1992-07-07 1994-01-20 Nancy M. Gray Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
JPH08512322A (ja) * 1993-07-06 1996-12-24 メルク エンド カンパニー インコーポレーテッド Ｈ▲下２▼拮抗剤−胃腸運動性の薬剤組合せ物
ATE182073T1 (de) * 1994-03-01 1999-07-15 Gerhard Gergely Ein brausesystem und einen arzneiwirkstoff enthaltendes granuläres produkt bzw. tablette sowie verfahren zu deren herstellung
CH686865A5 (de) * 1994-06-15 1996-07-31 Gergely Gerhard Pharmazeutische Zubereitung mit einem hydrophoben Wirkstoff und einem Brausesystem, sowie Verfahren zur Herstellung der Zubereitung.
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release

Also Published As

Publication number Publication date
EE9800269A (et) 1999-02-15
EA000804B1 (ru) 2000-04-24
KR970069038A (ko) 1997-11-07
AU720582B2 (en) 2000-06-08
WO1997039744A1 (en) 1997-10-30
US6030988A (en) 2000-02-29
NZ331705A (en) 1999-11-29
EE03552B1 (et) 2001-12-17
NO984016D0 (no) 1998-09-01
PL328917A1 (en) 1999-03-01
ZA973449B (en) 1998-10-22
BG102812A (en) 1999-05-31
CZ332598A3 (cs) 1999-01-13
JPH10510559A (ja) 1998-10-13
SK144698A3 (en) 1999-05-07
AR006790A1 (es) 1999-09-29
NO984016L (no) 1998-12-23
CA2201264A1 (en) 1997-10-23
EA199800861A1 (ru) 1999-02-25
CA2201264C (en) 1999-08-10
DE69713948D1 (de) 2002-08-22
CN1216467A (zh) 1999-05-12
KR100204115B1 (ko) 1999-06-15
BR9708585A (pt) 1999-08-03
ID16666A (id) 1997-10-30
TR199802139T2 (xx) 1999-03-22
AU2290497A (en) 1997-11-12
IL125979A0 (en) 1999-04-11

Similar Documents

Publication Publication Date Title
ATE220543T1 (de) Rasch-freisetzende ph-unabhängige feste dosisformen enthaltend cisaprid
NO972409D0 (no) Doseindikeringsanordning
DE59707194D1 (de) Direkttablettierhilfsmittel
PT925083E (pt) Seringas
ID18427A (id) Pengkabut serbuk
DE69618624D1 (de) Inhaliervorrichtung
NO990272L (no) Pulver-inhalator
DE69708327D1 (de) Pulverinhalator
IS4886A (is) Skömmtunarbúnaður fyrir einingarskammta
EE9700013A (et) Terapeutilised ühendid
FI962727A0 (fi) Potilasvalvontajärjestelmä
DE69731046D1 (de) Sicherheitsbehälter
DE69735754D1 (de) Impedanz-abhängiger implantierbarer kardiovertierer defribillator
NO983090D0 (no) Terapeutiske forbindelser
KR980000801U (ko) 경혈 지압구
DE59706259D1 (de) Palatinalsplitschraube
GB9626450D0 (en) Therapeutic compounds
KR970050954U (ko) 물리치료용 밴드
KR970056961U (ko) 손가락운동을 겸한 건강구
BR7700496U (pt) Unidade de exercício
NO965332D0 (no) Terapeutisk perparat
KR960035325U (ko) 분리형 감지기
NO963531D0 (no) Arbeidsstol
FIU960218U0 (fi) Tuoli
KR970064033U (ko) 브이씨알의 접지플레이트

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties